Abbott Laboratories Operating Margin 2010-2025 | ABT

Current and historical operating margin for Abbott Laboratories (ABT) over the last 10 years. The current operating profit margin for Abbott Laboratories as of March 31, 2025 is 19.81%.
Abbott Laboratories Operating Margin Historical Data
Date TTM Revenue TTM Operating Income Operating Margin
2025-03-31 $42.34B $7.13B 16.84%
2024-12-31 $41.95B $6.83B 16.27%
2024-09-30 $41.22B $6.69B 16.24%
2024-06-30 $40.73B $6.48B 15.92%
2024-03-31 $40.33B $6.36B 15.76%
2023-12-31 $40.11B $6.48B 16.15%
2023-09-30 $39.96B $6.00B 15.02%
2023-06-30 $40.23B $6.13B 15.23%
2023-03-31 $41.51B $6.96B 16.77%
2022-12-31 $43.65B $8.36B 19.16%
2022-09-30 $45.03B $9.44B 20.95%
2022-06-30 $45.55B $10.21B 22.42%
2022-03-31 $44.51B $9.23B 20.73%
2021-12-31 $43.08B $8.43B 19.56%
2021-09-30 $42.31B $8.48B 20.04%
2021-06-30 $40.23B $7.43B 18.46%
2021-03-31 $37.34B $6.71B 17.97%
2020-12-31 $34.61B $5.36B 15.48%
2020-09-30 $32.22B $4.31B 13.39%
2020-06-30 $31.44B $4.02B 12.78%
2020-03-31 $32.10B $4.55B 14.18%
2019-12-31 $31.90B $4.53B 14.21%
2019-09-30 $31.36B $4.31B 13.74%
2019-06-30 $30.94B $4.11B 13.27%
2019-03-31 $30.72B $3.78B 12.31%
2018-12-31 $30.58B $3.65B 11.94%
2018-09-30 $30.40B $3.14B 10.32%
2018-06-30 $29.58B $2.91B 9.84%
2018-03-31 $28.45B $2.41B 8.49%
2017-12-31 $27.39B $1.56B 5.71%
2017-09-30 $25.13B $1.70B 6.77%
2017-06-30 $23.61B $1.83B 7.75%
2017-03-31 $22.30B $2.26B 10.13%
2016-12-31 $20.85B $3.03B 14.51%
2016-09-30 $20.71B $3.05B 14.74%
2016-06-30 $20.56B $2.87B 13.95%
2016-03-31 $20.39B $2.78B 13.64%
2015-12-31 $20.41B $2.87B 14.05%
2015-09-30 $20.57B $2.88B 14.00%
2015-06-30 $20.50B $2.90B 14.13%
2015-03-31 $20.39B $2.84B 13.95%
2014-12-31 $20.25B $2.60B 12.84%
2014-09-30 $18.90B $2.19B 11.58%
2014-06-30 $18.65B $1.93B 10.37%
2014-03-31 $19.03B $1.88B 9.89%
2013-12-31 $19.66B $2.13B 10.85%
2013-09-30 $18.84B $1.69B 8.98%
2013-06-30 $19.28B $1.53B 7.93%
2013-03-31 $19.14B $1.47B 7.66%
2012-12-31 $19.05B $1.36B 7.14%
2012-09-30 $26.24B $3.47B 13.21%
2012-06-30 $30.79B $3.75B 12.18%
2012-03-31 $35.09B $4.96B 14.13%
2011-12-31 $38.85B $5.75B 14.80%
2011-09-30 $38.44B $5.50B 14.30%
2011-06-30 $37.30B $6.09B 16.31%
2011-03-31 $36.51B $5.92B 16.21%
2010-12-31 $35.17B $6.09B 17.31%
2010-09-30 $33.99B $6.12B 18.01%
2010-06-30 $33.08B $6.58B 19.89%
2010-03-31 $31.74B $6.65B 20.93%
2009-12-31 $30.76B $6.24B 20.27%
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $229.693B $41.950B
Abbott Labs discovers, develops, manufactures & sells a diversified line of health care products. Established Pharmaceuticals Division includes branded generics business in the emerging markets. Medical Devices unit includes the diabetes care, vision care & vascular businesses. Diagnostics unit manufactures and markets diagnostic systems and tests in four business lines core laboratory, molecular, point of care and rapid diagnostics. Nutrition unit includes a broad line of pediatric and adult nutritional products. Abbott acquired CFR Pharmaceuticals, Tendyne Holdings, Inc., St. Jude Medical and Alere Inc. On the other hand, Abbott sold its developed markets branded generics pharmaceuticals business to Mylan. Abbott retained the branded generics pharmaceuticals business in emerging markets. Abbott sold its animal health business to Zoetis Inc and divested its vision care business, Medical Optics, to Johnson & Johnson.
Stock Name Country Market Cap PE Ratio
Boston Scientific (BSX) United States $152.679B 38.22
Stryker (SYK) United States $148.653B 31.08
EssilorLuxottica (ESLOY) France $131.422B 0.00
Medtronic (MDT) Ireland $115.326B 16.35
Lonza Group Ag (LZAGY) Switzerland $49.666B 0.00
Haleon (HLN) United Kingdom $44.744B 25.54
ResMed (RMD) United States $37.302B 28.02
Agilent Technologies (A) United States $35.020B 22.83
GE HealthCare Technologies (GEHC) United States $34.401B 16.33
Terumo (TRUMY) Japan $24.607B 31.96
Koninklijke Philips (PHG) Netherlands $23.139B 16.24
Insulet (PODD) United States $20.361B 79.92
Zimmer Biomet Holdings (ZBH) United States $18.556B 11.92
Baxter (BAX) United States $14.728B 11.00
Smith & Nephew SNATS (SNN) United Kingdom $13.262B 0.00
Demant (WILYY) Denmark $8.971B 0.00
Sunny Optical Technology (SNPTF) China $8.561B 0.00
Bio-Rad Laboratories (BIO) United States $6.993B 24.33
Lantheus Holdings (LNTH) United States $5.626B 14.19
Perrigo (PRGO) Ireland $3.785B 9.59
Prestige Consumer Healthcare (PBH) United States $3.780B 16.89
Haemonetics (HAE) United States $3.628B 16.52
Shandong Weigao Medical Polymer (SHWGF) China $3.459B 0.00
Envista Holdings (NVST) United States $3.424B 28.45
ICU Medical (ICUI) United States $3.253B 23.99
QuidelOrtho (QDEL) United States $2.052B 14.11
LeMaitre Vascular (LMAT) United States $1.891B 42.26
AtriCure (ATRC) United States $1.521B 0.00
Acuren (TIC) United States $1.395B 0.00
Green Thumb Industries (GTBIF) United States $1.389B 31.24
Phibro Animal Health (PAHC) United States $1.248B 15.96
AdaptHealth (AHCO) United States $1.244B 12.63
Neogen (NEOG) United States $1.170B 14.97
BioLife Solutions (BLFS) United States $1.050B 0.00
InMode (INMD) Israel $0.930B 9.37
Curaleaf Holdings (CURLF) Canada $0.771B 0.00
Kestra Medical Technologies (KMTS) United States $0.766B 0.00
Maravai LifeSciences Holdings (MRVI) United States $0.695B 0.00
Owens & Minor (OMI) United States $0.627B 5.21
Evolus (EOLS) United States $0.611B 0.00
Tilray Brands (TLRY) Canada $0.584B 0.00
CeriBell (CBLL) United States $0.583B 0.00
Valneva SE (VALN) France $0.517B 0.00
Surmodics (SRDX) United States $0.441B 0.00
SNDL (SNDL) Canada $0.365B 0.00
Capricor Therapeutics (CAPR) United States $0.349B 0.00
VAREX IMAGING (VREX) United States $0.337B 12.38
Cresco Labs (CRLBF) United States $0.323B 0.00
SEMPERIT AG HLD (SEIGY) Austria $0.304B 0.00
Sanuwave Health (SNWV) United States $0.298B 0.00
Quanterix (QTRX) United States $0.294B 0.00
Cerus (CERS) United States $0.277B 0.00
Viemed Healthcare (VMD) United States $0.266B 22.47
Sanara MedTech (SMTI) United States $0.258B 0.00
Aurora Cannabis (ACB) Canada $0.252B 74.83
ZimVie (ZIMV) United States $0.251B 11.39
Verano Holdings (VRNOF) United States $0.235B 0.00
Brainsway (BWAY) Israel $0.233B 61.55
OraSure Technologies (OSUR) United States $0.232B 0.00
Biote (BTMD) United States $0.223B 6.28
Omeros (OMER) United States $0.214B 0.00
Canopy Growth (CGC) Canada $0.208B 0.00
Organigram Global (OGI) Canada $0.194B 0.00
High Tide (HITI) Canada $0.191B 0.00
TriSalus Life Sciences (TLSI) United States $0.185B 0.00
Utah Medical Products (UTMD) United States $0.183B 14.93
Vireo Growth (VREOF) United States $0.163B 0.00
Exagen (XGN) United States $0.149B 0.00
FitLife Brands (FTLF) United States $0.122B 0.00
TerrAscend (TSNDF) Canada $0.117B 0.00
MacroGenics (MGNX) United States $0.102B 0.00
Jin Medical (ZJYL) China $0.100B 0.00
Fonar (FONR) United States $0.098B 12.68
Jushi Holdings (JUSHF) United States $0.090B 0.00
Veru (VERU) United States $0.088B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.087B 0.00
Quipt Home Medical (QIPT) United States $0.081B 0.00
Apyx Medical (APYX) United States $0.079B 0.00
Agape ATP (ATPC) $0.074B 0.00
InterCure (INCR) Israel $0.071B 0.00
Zynex (ZYXI) United States $0.068B 0.00
Cytosorbents (CTSO) United States $0.066B 0.00
ImmuCell (ICCC) United States $0.059B 0.00
Rockwell Medical (RMTI) United States $0.039B 0.00
Modular Medical (MODD) United States $0.039B 0.00
Nephros (NEPH) United States $0.038B 51.43
United-Guardian (UG) United States $0.037B 12.89
Safety Shot (SHOT) United States $0.034B 0.00
Allurion Technologies (ALUR) United States $0.021B 0.00
Flora Growth (FLGC) United States $0.015B 0.00
INLIF (INLF) $0.015B 0.00
Meihua Medical Technologies (MHUA) China $0.015B 0.00
Trinity Biotech (TRIB) Ireland $0.014B 0.00
IM Cannabis (IMCC) Canada $0.012B 0.00
Senestech (SNES) United States $0.011B 0.00
Cellectar Biosciences (CLRB) United States $0.009B 0.00
Innovative Eyewear (LUCY) United States $0.007B 0.00
Sharps Technology (STSS) United States $0.006B 0.00
GlucoTrack (GCTK) United States $0.003B 0.00
Akanda (AKAN) Canada $0.002B 0.00
InVivo Therapeutics Holdings (NVIVQ) United States $0.000B 0.00